Sarasota Memorial Enrolls First Patient in Novel Clinical Trial for the Treatment of Papillary Thyroid Cancer

Sarasota Memorial is one of two research sites evaluating the effectiveness of a novel, minimally invasive treatment for papillary thyroid cancer. The study is led locally by Ralph P. Tufano, MD, MBA, FACS, thyroid and parathyroid surgeon with Sarasota Memorial’s Brian D. Jellison Cancer Institute, in collaboration with SMH’s Kolschowsky Research and Education Institute and principal investigator Victoria Banuchi, M.D., associate professor of Head & Neck Surgery at The University of Texas MD Anderson Cancer Center. A total of 30 patients will be enrolled across the two study sites.

Thursday, March 26, 2026

Sarasota Memorial Hospital Earns National Recognition for Excellence in Maternity Care

Sarasota Memorial Hospital (SMH) has been named among America’s “Best Hospitals for Maternity Care” for delivering high-quality, patient-centered care to mothers and newborns.

Tuesday, March 24, 2026

Sarasota Memorial Studies Novel Pacing Approach for Heart Failure Patients

Many heart failure patients receive implanted devices to help their hearts beat more efficiently, but a significant number don’t achieve the benefits doctors hope for. Sarasota Memorial recently joined an international trial to evaluate a new pacing approach that may help more patients benefit from this life-saving technology.

Wednesday, March 11, 2026

Sarasota Neurosurgeons Join SMH’s First Physicians Group

Sarasota Memorial is pleased to announce that Sarasota-based Neurosurgery and Spine Specialists has joined the health system’s First Physicians Group network.

Friday, March 6, 2026

SMH Chief Medical Officer Honored Among ‘CMOs to Know’

Sarasota Memorial Health Care System (SMH) is proud to announce that Chief Medical Officer James Fiorica, MD, has been named to Becker’s Hospital Review’s 2026 list of “Chief Medical Officers to Know.”

Tuesday, March 3, 2026